Navigation Links
OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
Date:6/17/2010

REDWOOD CITY, Calif., June 17 /PRNewswire/ -- OncoMed Pharmaceuticals, Inc. and Bayer Schering Pharma AG, Germany, today announced a global strategic alliance to discover, develop and commercialize novel anti-cancer stem cell therapeutics targeting the Wnt signaling pathway.  Cancer stem cells are a subset of tumor cells believed to play a significant role in the establishment, metastasis and recurrence of cancer.  

The strategic alliance leverages OncoMed's leadership in cancer stem cell drug discovery and development.  Under the terms of the agreement, Bayer and OncoMed will develop antibodies, protein therapeutics, and small molecules as potential novel anti-cancer stem cell therapeutics targeting the Wnt signaling pathway.  In addition to an upfront cash payment of $40 million, OncoMed is eligible to receive cash payments for product candidates that Bayer Schering Pharma options and possible additional payments upon achievement of certain development and commercialization milestones described below.  The collaboration could potentially include up to five compounds. The agreement includes potential significant near-term milestone payments from Bayer.

OncoMed will utilize its proprietary human cancer stem cell models to discover and advance antibody and protein therapeutics through Phase I clinical studies.  Bayer Schering Pharma receives an option to exclusively license antibody and protein therapeutic product candidates at any point up to the completion of Phase I testing.  Following option exercise, Bayer will lead development and commercialization of licensed product candidates.  For each biotherapeutic drug candidate successfully developed through Phase III clinical trials and regulatory approval, OncoMed's payments
'/>"/>

SOURCE OncoMed Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals Lead Antibody
2. OncoMed Pharmaceuticals Appoints Sunil Patel Senior Vice President, Corporate Development
3. OncoMed Pharmaceuticals Completes Series B Financing
4. Oramed Pharmaceuticals was Chosen to Present Two Abstracts at the 70th Scientific Sessions of the American Diabetes Association in Orlando, FL, June 25-29, 2010
5. Isis Pharmaceuticals to Discuss Its Neurodegenerative Franchise in a Conference Call on Thursday, June 17
6. Anthera Pharmaceuticals Promotes Colin Hislop, M.D., to Chief Medical Officer
7. INTUNIV(TM) - Shire Files Suit Against Anchen Pharmaceuticals, Inc. and Anchen, Inc.
8. OncoGenex Pharmaceuticals to Present at the 9th Annual Needham Healthcare Conference
9. Amylin Pharmaceuticals to Present at the 2010 Jefferies Global Life Sciences Conference
10. Merrimack Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference
11. Merrimack Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains ... these latent viruses is the Epstein Barr Virus (EBV), and ... (RA) is a chronic inflammatory disease that destroys the body’s ... RA patients have high concentrations of EBV DNA in their ...
(Date:1/15/2014)... 2014 Freeslate, Inc ., the ... that Lupin Limited, one of India’s top five pharmaceutical ... PharmD System for high throughput solid form screening. ... on a wide range of quality, affordable generic and ...
(Date:1/14/2014)... January 14, 2014 Date: Friday, April 11, ... Warrington Country Club, 1360 Almshouse Road, Warrington, Pa. ... organization solely dedicated to finding a cure for hepatitis B ... will host its annual Crystal Ball on Friday, April 11 ...
(Date:1/14/2014)... Jan. 14, 2014  3D Communications, a leading provider of strategic communications ... and media events in the United States ... Virginia Cox , JD, is returning to the firm,s ... re-joins 3D after more than two years of service as ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... 6 Omeros Corporation today announced that The Michael ... against milestones to support the Company,s collaboration with The ... new target for the treatment of Parkinson,s disease. Located ... Omeros is the first to link its novel target ...
... N.Y., Jan. 6 Dedicated to the memory ... fields of angiogenesis and vasculogenesis and shed light on the ... special double issue (Volume 6, Number 3-4) of ... papers that reflect the research impact of one of the ...
... Jan. 6 AutoGenomics, a leader in providing automated, ... been invited and has accepted to present at the ... 2009 at the Westin St. Francis Hotel in San ... CEO will provide an overview of the Company at ...
Cached Biology Technology:Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinson's Disease Target 2Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinson's Disease Target 3Festschrift Issue Honoring Judah Folkman, M.D. in Lymphatic Research and Biology 2Festschrift Issue Honoring Judah Folkman, M.D. in Lymphatic Research and Biology 3
(Date:7/9/2014)... how a complex protein pivotal in the development of ... discovery answers a key question about one of the ... the subject of tens of thousands of research papers ... Zhang, a research student in Professor Sir Philip Cohen,s ... protein complex, called NF-κB, is activated. The results ...
(Date:7/9/2014)... associate professor of plant pathology and microbiology ... the 2014 Alexopoulos Prize by the Mycological ... the science of mycology the study of fungi ... plant pathogens, and medically important fungi. , The award ... mycologist. Stajich received the award last month in East ...
(Date:7/9/2014)... selection refers to species, selection for traits that are ... natural selection enhances opportunities to mate, the tail of ... the University of California, Riverside have now found that ... placenta are linked. Describing the life histories of ... Poeciliidae, the researchers found that species with placentas tend ...
Breaking Biology News(10 mins):Research reveals how key controller protein is switched on 2UC Riverside plant pathologist receives national recognition 2Biologists link sexual selection and placenta formation 2Biologists link sexual selection and placenta formation 3Biologists link sexual selection and placenta formation 4
... Ph.D., assistant professor of chemistry in Arts & ... the National Institute of Mental Health for research ... Wiring." Maurer,s long term objective is ... a variety of neuronal wiring processes. He is ...
... KSContact with nature has long been suspected to ... from the pain associated with recovery from surgery. ... plants and flowers for patients recovering from abdominal ... and Richard H. Mattson, researchers from the Department ...
... New research in an animal model suggests that a ... a variety of processed foods including meats, cheeses, beverages, ... tumors and may even contribute to the development of ... The study also suggests that dietary regulation of inorganic ...
Cached Biology News:Chemist receives NIH funding to unravel tricks of neuronal wiring 2Flowering plants speed post-surgery recovery 2Common food additive found to increase risk and speed spread of lung cancer 2Common food additive found to increase risk and speed spread of lung cancer 3
Alkaline Phosphatase (E. coli C75), 100 units. Removes 5'-phosphates from DNA. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzymes, Alkaline Phosphatases....
... CyScribe First-Strand cDNA Labeling System - ... 50 reactions. For the generation and ... reagents are packaged together for complete ... protocols can be used for performing ...
... Post-Labeling Reactive Dye Pack, 12 x ... specifically optimized for microarray labeling.Higher reactivity ... reactive dye per vial, at > ... individually dispensed, and packed in foil ...
... CyScribe GFX Purification Kit, 24 reactions. ... Cy3- and Cy5-labeled cDNA.Optimized reagents are ... and purification.Flexible and optimized protocols can ... with either Cy3- or Cy5-labeled nucleotides.Reliable ...
Biology Products: